Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Adaptive Biotechnologies | 621 | 2023q3 | |||||||||
Agilent Technologies | 41,656 | 2023q1 | |||||||||
Bio-Rad Laboratories | 10,214 | 2023q3 | |||||||||
Bionano Genomics | 40 | 2023q3 | |||||||||
Bruker | 13,778 | 2022 | |||||||||
Champions Oncology | 66 | 2024q2 | |||||||||
Co-Diagnostics | 36 | 2023q3 | |||||||||
Danaher | 182,272 | 2021 | |||||||||
EXACT Sciences | 10,769 | 2023q1 | |||||||||
Fulgent Genetics | 720 | 2021 | |||||||||
Haemonetics | 0 | 2025q1 | |||||||||
ICON | 27,388 | 2023 | |||||||||
IDEXX Laboratories | 44,097 | 2023 | |||||||||
Illumina | 18,589 | 2023q2 | |||||||||
Maravai LifeSciences Hold... | 0 | 2024q2 | |||||||||
Mettler-Toledo Internatio... | 22,402 | 2023q3 | |||||||||
Motus GI Holdings | 9 | 2022q3 | |||||||||
Myriad Genetics | 0 | 2024q2 | |||||||||
Natera | 9,661 | 2022 | |||||||||
OPKO Health | 857 | 2023 |